Todays Market from Equitymaster #educratsweb
HOME | LATEST JOBS | JOBS | CONTENTS | STUDY MATERIAL | CAREER | NEWS | BOOK | VIDEO | PRACTICE SET REGISTER | LOGIN | CONTACT US

Todays Market from Equitymaster

http://feeds.equitymaster.com/TodaysMarket?format=HTML 👁 1372

Will Low Inflation Encourage RBI to Cut Rates?


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

In a week full of macroeconomic developments, anxiety over third quarter results and trade war concerns, we take a look at the key topics that swayed the markets this week.

Indian stock markets traded flat-to-positive this week. Market participants were cautious ahead of the quarterly results. And global concerns over US-China trade tensions capped gains.

We talk about the recently released macroeconomic data. India's retail inflation and wholesale inflation fell to multi-month lows in December amid signs of weakening economic recovery. With the fall in inflation numbers, top business groups urged the RBI to cut its benchmark interest rate.

So, will this request fall on deaf ears, or would the newly appointed Governor pay the request some heed?

Meanwhile, India's trade deficit also narrowed in December.

Then, we also talk about Jet Airways woes and what lies ahead of the airline company.

At the end of this podcast episode, we will talk about free online summit to be held this month. It will help you know how to amass life-changing wealth from India's rise to the pinnacle�it last occupied nearly 2,000 years ago!

Tune in!



This article (Will Low Inflation Encourage RBI to Cut Rates?) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/FGY31dqWuEI/tm.asp

Sensex Ends Marginally Higher; Oil & Gas Stocks Witness Buying


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

Share markets in India ended their trading session marginally higher. Sectoral indices ended on a mixed note with stocks in the energy sector trading in the green and stocks from the telecom sector witnessing most of the selling pressure.

At the closing bell, the BSE Sensex stood higher by 13 points (up 0.03%) and the NSE Nifty stood flat. The BSE Mid Cap index ended the day down 0.8%, while the BSE Small Cap index ended the day down by 0.7%.

The rupee was trading at 71.14 against the US$.

Asian stock markets finished on a positive note. As of the most recent closing prices, the Hang Seng was up by 0.5% and the Nikkei 225 was up by 1.3%.

Stocks from the auto sector were trading on a negative note today with Bharat Forge and TVS Motors witnessing most of the selling pressure.

Speaking of the auto sector, note that one out of every three household in India is a buyer of their products. They own some of the cult brands in Indian automobile space.

--- Advertisement ---
India is Set to Regain Its Lost Riches

REBIRTH OF INDIA India was the world's richest country nearly 2,000 years ago. In fact, we were referred to as the "Sone Ki Chidiya."

If you are like us who believe that India has the potential to be once again the "Sone Ki Chidiya" to the world again…and regain its status as one among the greatest countries on earth…

Then, I encourage you to join other true Indians in the first-ever mega summit "REBIRTH OF INDIA" for FREE.

This is our LARGEST EVER FREE PUBLIC SUMMIT available for EVERY INDIAN CITIZEN.

Don't Miss it!

Click Here to Claim Your FREE Pass for this MEGA Summit…
------------------------------

They have formidable R&D teams. They have been through several economic cycles over decades. Few have even visited near-bankruptcy in the past and come out successful.

Yet, some of the biggest passenger car, commercial vehicle, and two-wheeler companies in India have seen a huge dent in valuations in recent times. This is evident in the chart below:

Bluechip Auto Are Stocks Way Off Their Valuation Peaks

Tanushree Banerjee, Co-head of Research at Equitymaster believes, this could be the opportunity long term investors were waiting for.

In the news from pharma space, Aurobindo Pharma share price was in focus today as the company said it had acquired seven marketed oncology injectable products from Spectrum Pharmaceuticals for about US$ 300 million.

This includes an upfront cash payment of up to US$ 160 million and up to US$ 140 million in milestones.

In the news from airlines space, Jet Airways share price is in focus today as promoter Naresh Goyal has countered partner Etihad Airways' proposal to increase stake in the airline with an offer to invest Rs 7 billion.

As per the news, he has also proposed to pledge his entire shareholding with lenders while seeking to maintain at least a 25% stake. This is done so to resist pressure to reduce his holding and step aside.

Note that Etihad Airways is seeking a hard bargain, given the imminent risk of the grounding of aircraft by lessors, thereby triggering a rapid cessation of operations.

As per the news, a report suggested that Etihad Airways CEO Tony Douglas has communicated to the lead lender that it will not pay more than Rs 150 a share for infusing funds and sought a complete exit by Naresh Goyal and his family from any management or even advisory role in the Indian carrier.

Etihad has offered to invest in the domestic airline at discounted rate of Rs 150 per share. Along with this, Etihad has also agreed to infuse US$ 35 million from Jet Privilege, where it owns majority shares but after the due diligence is completed.

Etihad Chief Executive Tony Douglas has written to State Bank of India on the restructuring plan for the airline.

As per an article in The Economic Times, Etihad has sought exemptions from the markets regulator from making an open offer and preferential pricing guidelines.

Here's an excerpt from the article:

  • In addition, Etihad is also demanding that Mr. Goyal's future role as "Chairman Emeritus" should be "well defined," stressing that no board seat should be given for Mr. Goyal himself and no rights for him or his family and affiliates to act or represent the airline.

Shares of the company rallied around 18% in Monday's trading session on reports that the company is close to finalizing a resolution plan.

Last Friday, reports stated that the Tata-Jet Airways deal is back on the table.

The cash-strapped airline which had its credit rating cut to default this month is weighing a resumption of stake sale talks with Tata Group as the carrier is poised to run out of cash.

The creditors are open to lending US$ 500 million to Jet Airways if Goyal and Etihad inject a similar amount into the company. A decision will be made once a forensic examination being conducted into the airline's book is completed.

Jet's woes have worsened with higher oil prices and intense competition in 2018.

This would be the second time that the West Asian airline has come to the debt-laden carrier's rescue.

To know more about the company, you can access to Jet Airways' latest result analysis and Jet Airways' 2017-18 Annual Report Analysis on our website.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.



This article (Sensex Ends Marginally Higher; Oil & Gas Stocks Witness Buying) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/r0vqMAmBUsY/tm.asp

Sensex Trades Marginally Lower; Telecom & Healthcare Stocks Drag


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

Share markets in India are presently trading on a negative note. Barring energy sector, all sectoral indices are trading in red with stocks in the telecom sector, FMCG sector and healthcare sector witnessing maximum selling pressure.

The BSE Sensex is trading down by 81 points (down 0.2%), while the NSE Nifty is trading down by 26 points (down 0.2%). The BSE Mid Cap index is trading down by 0.4% and the BSE Small Cap index is trading down by 0.5%.

The rupee is trading at Rs 71.14 against the US$.

Market participants are tracking Wipro, NIIT Technologies, L&T Infotech, Dhanlaxmi Bank as they announce their December ended quarter results today.

In the latest development from the results corner, Hindustan Unilever share price has posted 9% growth in its net profit at Rs 14.4 billion as compared to Rs 13.3 billion in the same period last year.

Revenues came in at Rs 93.6 billion in Q3FY19, witnessing a growth of 12.4% against Rs 83.2 billion in Q3FY18.

To know more about the company you can read HUL Q3FY19 Result Analysis and HUL Annual Report Analysis on our website.

You can also read our recently released Q3FY19 results: Zee Entertainment's latest result analysis, Reliance Industries, Federal Bank, Infosys, TCS, Trident.

In the news from the commodity space, oil prices edged higher today after a report from the Organization of the Petroleum Exporting Countries (OPEC) showed its production fell sharply last month, easing fears about prolonged oversupply.

--- Advertisement ---
India is Set to Regain Its Lost Riches

REBIRTH OF INDIA India was the world's richest country nearly 2,000 years ago. In fact, we were referred to as the "Sone Ki Chidiya."

If you are like us who believe that India has the potential to be once again the "Sone Ki Chidiya" to the world again…and regain its status as one among the greatest countries on earth…

Then, I encourage you to join other true Indians in the first-ever mega summit "REBIRTH OF INDIA" for FREE.

This is our LARGEST EVER FREE PUBLIC SUMMIT available for EVERY INDIAN CITIZEN.

Don't Miss it!

Click Here to Claim Your FREE Pass for this MEGA Summit…
------------------------------

Looking at oil supplies, 2019 crude prices have been supported by supply cuts from a group of producers around the Middle East-dominated Organization of the Petroleum Exporting Countries (OPEC) as well as non-OPEC member Russia.

OPEC oil supply fell by 460,000 barrels per day (bpd) between November and December, to 32.7 million bpd, as top exporter Saudi Arabia made an early start to a supply-limiting accord, while Iran and Libya posted involuntary declines.

It would be interesting to see how this pans out. Meanwhile, we will keep you updated on all the developments from this space.

Moving on to the news from the pharma space, Sun Pharma share price is witnessing selling pressure today on reports that new whistleblower documents had been sent to the markets regulator.

According to a news report by a financial news website, huge transactions of over Rs 58 billion allegedly took place between Aditya Medisales and private companies of Sun Pharma's promoters between 2014 and 2017.

This is as per a new 172-page complaint (with documents) sent by the whistleblower on Sun Pharma to the markets regulator.

Shares of the company fell as much as 12% today on back of the above news.

Last month, a note by Macquarie, an Australian brokerage firm went viral which raised concerns among the investing community.

The note raised questions about inadequate disclosures regarding the role of promoter Dilip Shanghvi's brother-in-law Sudhir Valia, Sun Pharma's past links with banned traders Ketan Parekh and Dharmesh Doshi, related party transactions involving promoter Shanghvi and guarantees given to real estate firm Suraksha Realty.

In November, a whistleblower had approached markets regulator with a document alleging various irregularities by the company, its promoter Shanghvi and others.

The whistleblower made allegations in a 150-page letter sent to the markets regulator, which had earlier banned Doshi and Parekh following the 2001 scam.

According to the news in a leading financial daily, the irregularities involved two or three major rounds of foreign currency convertible bonds (FCCBs) issues by Sun Pharma during 2002-2007, which was managed by Jermyn Capital LLC.

The markets regulator reportedly is planning to reopen the investigation into the insider trading case against the company and its promoters which was settled through consent mechanism.

Speaking of pharma sector, note that the BSE Healthcare Index has been on a roller coaster ride in the past few years. The period from 2012 to 2015 saw the index go up more than three times.

And since then it has been a painful ride downwards, as can be seen from the chart below:

The Roller Coaster Ride of the BSE Healthcare Index

As we wrote in one of our editions of The 5 Minute WrapUp...

  • Pre-2015, pharma companies enjoyed a fairytale ride in the US market. Low labor costs, good chemistry skills, along with efficiency, ensured Indian companies could copy innovator drugs to make generic drugs at a fast pace.

    The generic business had lucrative margins for all major pharma players. But the party did not last long. In the quest to supply drugs quickly, they compromised on quality at their manufacturing facilities.

    No wonder, the US regulatory authority (USFDA) took strict action. Sun Pharma received a warning letter for its Halol manufacturing facility in 2015. It was like a bolt out of the blue. Since then, the downward spiral began and has continued till date.

We believe that pharma companies that invest in creating a pipeline of complex generics or building competencies in alternative dosage forms are better equipped to tackle the changing dynamics in the US generics market as well as in the overall industry.

To know more on what moved the Indian stock markets today, you can check out the most recent share market updates here.



This article (Sensex Trades Marginally Lower; Telecom & Healthcare Stocks Drag) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/VlVvn88cpJA/tm.asp

SUN TV Plunges by 5%; BSE 500 Index Down 0.3%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

SUN TV share price has plunged 5% and is presently trading at Rs 568.

Meanwhile, the BSE 500 Index is at 14,557 (down 0.3%).

Among the top losers in the BSE 500 Index today are SUN TV (down 5.2%) and BHARTI AIRTEL (down 5.8%).

SREI INFRA FINANCE (up 3.7%) and HIND. CONSTRUCTION (up 3.6%) are among the top gainers today.

Over the last one year, SUN TV has moved down from Rs 1,060 to Rs 568, registering a loss of Rs 491 (down 46.4%)..

The BSE 500 has moved down from 15,328 to 14,557, loss of 771 points (down 5.0%) during the last 12 months.

The top gainers among the BSE 500 Index stocks during this same period were NIIT TECHNOLOGIES (up 72.1%), L&T TECHONOLOGY SERVICES (up 65.8%) and VINATI ORG. (up 62.6%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 (down 0.2%). The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.2%). The most traded stocks in the BSE Sensex are ICICI BANK and RELIANCE IND..

In the meantime, NSE Nifty is at 10,928 (down 0.2%). WIPRO (up 1.6%) and RELIANCE IND. (up 1.3%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.4%).

SUN TV Financial Update...

SUN TV net profit stood at Rs 4 billion for the quarter ended September 2018, compared to a profit of Rs 3 billion a year ago. Net Sales rose 9.7% to Rs 7.5 billion during the period as against Rs 6.8 billion in July-September 2017.

For the year ended March 2018, SUN TV reported 11.1% increase in net profit to Rs 11.1 billion compared to net profit of Rs 10.0 billion during FY17.

Revenue of the company grew 12.0% to Rs 30 billion during FY18.

The current Price to earnings ratio of SUN TV, based on rolling 12 month earnings, stands at 16.1x.

This article (SUN TV Plunges by 5%; BSE 500 Index Down 0.3%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/Rm1yL5QMfTg/indian-share-markets-updates.asp

VODAFONE IDEA Plunges by 5%; BSE 500 Index Down 0.2%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

VODAFONE IDEA share price has plunged 5% and is presently trading at Rs 37.

Meanwhile, the BSE 500 Index is at 14,557 (down 0.2%).

Among the top losers in the BSE 500 Index today are VODAFONE IDEA (down 5.2%) and BHARTI AIRTEL (down 5.6%).

SREI INFRA FINANCE (up 4.2%) and HIND. CONSTRUCTION (up 4.1%) are among the top gainers today.

Over the last one year, VODAFONE IDEA has moved down from Rs 103 to Rs 37, registering a loss of Rs 66 (down 63.8%)..

The BSE 500 has moved down from 15,328 to 14,557, loss of 771 points (down 5.0%) during the last 12 months.

The top gainers among the BSE 500 Index stocks during this same period were NIIT TECHNOLOGIES (up 72.3%), L&T TECHONOLOGY SERVICES (up 65.8%) and VINATI ORG. (up 62.6%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 (down 0.1%). The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.3%). The most traded stocks in the BSE Sensex are ICICI BANK and RELIANCE IND..

In the meantime, NSE Nifty is at 10,928 (down 0.2%). WIPRO (up 1.5%) and KOTAK MAH. BANK (up 1.1%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.6%).

VODAFONE IDEA Financial Update...

VODAFONE IDEA net profit down at Rs 50 billion for the quarter ended September 2018, compared to a loss of Rs 13 billion a year ago. Net Sales rose 17.7% to Rs 76.6 billion during the period as against Rs 65.1 billion in July-September 2017.

For the year ended March 2018, VODAFONE IDEA reported 446.6% increase in net profit to Rs 44.9 billion compared to net profit of Rs 8.2 billion during FY17.

Revenue of the company grew 20.5% to Rs 283 billion during FY18.

The current Price to earnings ratio of VODAFONE IDEA, based on rolling 12 month earnings, stands at down 6.1x.

This article (VODAFONE IDEA Plunges by 5%; BSE 500 Index Down 0.2%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/tQY71FnreVI/indian-share-markets-updates.asp

BHARTI AIRTEL Plunges by 5%; BSE 500 Index Down 0.2%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

BHARTI AIRTEL share price has plunged 5% and is presently trading at Rs 332.

Meanwhile, the BSE 500 Index is at 14,557 (down 0.2%).

Among the top losers in the BSE 500 Index today are BHARTI AIRTEL (down 5.1%) and HSIL LTD (down 5.9%).

SREI INFRA FINANCE (up 4.2%) and HIND. CONSTRUCTION (up 4.1%) are among the top gainers today.

Over the last one year, BHARTI AIRTEL has moved down from Rs 500 to Rs 332, registering a loss of Rs 168 (down 33.6%)..

The BSE 500 has moved down from 15,328 to 14,557, loss of 771 points (down 5.0%) during the last 12 months.

The top gainers among the BSE 500 Index stocks during this same period were NIIT TECHNOLOGIES (up 72.9%), L&T TECHONOLOGY SERVICES (up 65.6%) and VINATI ORG. (up 62.6%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 (down 0.1%). The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.3%). The most traded stocks in the BSE Sensex are ICICI BANK and RELIANCE IND..

In the meantime, NSE Nifty is at 10,928 (down 0.2%). RELIANCE IND. (up 1.3%) and ONGC (up 1.2%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.5%).

BHARTI AIRTEL Financial Update...

BHARTI AIRTEL net profit down at Rs 859 million for the quarter ended September 2018, compared to a loss of Rs 6 billion a year ago. Net Sales rose 0.5% to Rs 204.2 billion during the period as against Rs 203.2 billion in July-September 2017.

For the year ended March 2018, BHARTI AIRTEL reported 45.0% decrease in net profit to Rs 29.8 billion compared to net profit of Rs 54.1 billion during FY17.

Revenue of the company grew 12.3% to Rs 837 billion during FY18.

The current Price to earnings ratio of BHARTI AIRTEL, based on rolling 12 month earnings, stands at 105.3x.

This article (BHARTI AIRTEL Plunges by 5%; BSE 500 Index Down 0.2%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/u-hHmTAE5kI/indian-share-markets-updates.asp

HIND. CONSTRUCTION Surges by 7%; BSE REALTY Index Down 0.0%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

HIND. CONSTRUCTION share price has zoomed 7% and is presently trading at Rs 14.

Meanwhile, the BSE REALTY Index is at 1,883 .

Among the top Gainers in the BSE REALTY Index today is HIND. CONSTRUCTION (up 6.6%).

HOUSING DEV. INFRA (down 0.4%) and INDIABULLS REAL EST (down 0.5%) are among the top losers today.

Over the last one year, HIND. CONSTRUCTION has moved down from Rs 34 to Rs 14, registering a loss of Rs 20 (down 59.3%).

On the other hand, the BSE REALTY has moved down from 2,700 to 1,883, loss of 817 points (down 30.7%) during the last 12 months.

The top gainers among the BSE REALTY Index stocks during this same period were [param_historic_top3].

What About the Benchmark Indices?

The BSE Sensex is at 36,470 (down 0.2%).

The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.4%), ONGC (up 1.2%) and VEDANTA LTD (up 0.6%). Other gainers include ICICI BANK (up 0.6%) and POWER GRID (up 0.5%). The most traded stocks in the BSE Sensex are ICICI BANK and RELIANCE IND..

In the meantime, NSE Nifty is at 10,928 (down 0.1%). RELIANCE IND. (up 1.5%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.5%).

HIND. CONSTRUCTION Financial Update...

HIND. CONSTRUCTION net profit stood at Rs 25 billion for the quarter ended September 2018, compared to a profit of Rs 313 million a year ago. Net Sales declined 20.1% to Rs 9.8 billion during the period as against Rs 12.3 billion in July-September 2017.

For the year ended March 2018, HIND. CONSTRUCTION reported 2.8% increase in net profit to Rs 8.9 billion compared to net profit of Rs 8.7 billion during FY17.

Revenue of the company grew 2.7% to Rs 101 billion during FY18.

The current Price to earnings ratio of HIND. CONSTRUCTION, based on rolling 12 month earnings, stands at 0.6x.

This article (HIND. CONSTRUCTION Surges by 7%; BSE REALTY Index Down 0.0%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/EmIU7f0dLvU/indian-share-markets-updates.asp

PHILLIPS CARBON BLACK Plunges by 5%; BSE 500 Index Down 0.2%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

PHILLIPS CARBON BLACK share price has plunged 5% and is presently trading at Rs 208.

Meanwhile, the BSE 500 Index is at 14,557 (down 0.2%).

Among the top losers in the BSE 500 Index today are PHILLIPS CARBON BLACK (down 5.2%) and SUN PHARMA ADV. RES. (down 8.2%).

HIND. CONSTRUCTION (up 6.6%) and SREI INFRA FINANCE (up 4.8%) are among the top gainers today.

Over the last one year, PHILLIPS CARBON BLACK has moved down from Rs 262 to Rs 208, registering a loss of Rs 54 (down 20.6%)..

The BSE 500 has moved down from 15,328 to 14,557, loss of 771 points (down 5.0%) during the last 12 months.

The top gainers among the BSE 500 Index stocks during this same period were NIIT TECHNOLOGIES (up 72.5%), L&T TECHONOLOGY SERVICES (up 66.8%) and VINATI ORG. (up 62.6%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 (down 0.2%). The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.4%). The most traded stocks in the BSE Sensex are ICICI BANK and RELIANCE IND..

In the meantime, NSE Nifty is at 10,928 (down 0.1%). RELIANCE IND. (up 1.5%) and ONGC (up 1.4%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.5%).

PHILLIPS CARBON BLACK Financial Update...

PHILLIPS CARBON BLACK net profit stood at Rs 1 billion for the quarter ended December 2018, compared to a profit of Rs 566 million a year ago. Net Sales rose 54.5% to Rs 9.5 billion during the period as against Rs 6.1 billion in October-December 2017.

For the year ended March 2018, PHILLIPS CARBON BLACK reported 234.3% increase in net profit to Rs 2.3 billion compared to net profit of Rs 687.0 million during FY17.

Revenue of the company grew 22.0% to Rs 26 billion during FY18.

The current Price to earnings ratio of PHILLIPS CARBON BLACK, based on rolling 12 month earnings, stands at 1.7x.

This article (PHILLIPS CARBON BLACK Plunges by 5%; BSE 500 Index Down 0.2%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/yR6F51vKy3s/indian-share-markets-updates.asp

The BSE HEALTHCARE Index Down 2% ; SUN PHARMA Among Top Losers


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

The BSE HEALTHCARE Index has plunged 2% to 14,091.

Among the top losers in the BSE HEALTHCARE Index today are SUN PHARMA (down 10.2%), SUN PHARMA ADV. RES. (down 8.2%) and PANACEA BIOTECH (down 4.3%). Other losers include STRIDES PHARMA SCIENCE (down 4.1%) and DIL LIMITED (down 4.0%).

BIOCON LTD (up 2.1%) and SEQUENT SCIENTIFIC (up 1.8%) are among the top gainers today.

In the meantime, the NIFTY PHARMA has plunged 2.7% to 8,913.

The top losers in the NIFTY PHARMA include SUN PHARMA (down 10.3%), PANCHSHEEL ORG (down 9.2%) and BETA DRUGS LTD (down 6.3%). Other losers include AMAR REMEDIES (down 4.9%) and KDL BIOTECH (down 4.6%).

Over the last one year, the BSE HEALTHCARE Index has moved down from 14,973 to 14,091, loss of Rs 882 (down 5.9%).

The top losers among the BSE HEALTHCARE during this same period were SUN PHARMA ADV. RES. (down 69.0%), VIVIMED LABS LTD (down 67.2%) and RPG LIFE SCIENCES (down 58.7%).

What about the Benchmark Indices?

Meanwhile, the BSE Sensex has plunged 0.3% to 36,470.

Among the top gainers in the BSE Sensex today are RELIANCE IND. (up 1.1%), ONGC (up 0.9%) and POWER GRID (up 0.5%). Other gainers include KOTAK MAH. BANK (up 0.5%) and VEDANTA LTD (up 0.4%).

The most traded stocks in the BSE Sensex are ICICI BANK and RELIANCE IND..

In the meantime, the NSE Nifty is at 10,928 (down 0.1%).



This article (The BSE HEALTHCARE Index Down 2% ; SUN PHARMA Among Top Losers) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/ISFU3OTlVCs/indian-share-markets-updates.asp

HSIL LTD Plunges by 6%; BSE 500 Index Down 0.4%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

HSIL LTD share price has plunged 6% and is presently trading at Rs 243.

Meanwhile, the BSE 500 Index is at 14,557 (down 0.4%).

Among the top losers in the BSE 500 Index today are HSIL LTD (down 5.8%) and SUN PHARMA ADV. RES. (down 8.0%).

SREI INFRA FINANCE (up 4.2%) and STERLITE TECH. (up 2.2%) are among the top gainers today.

Over the last one year, HSIL LTD has moved down from Rs 487 to Rs 243, registering a loss of Rs 244 (down 50.1%)..

The BSE 500 has moved down from 15,328 to 14,557, loss of 771 points (down 5.0%) during the last 12 months.

The top gainers among the BSE 500 Index stocks during this same period were NIIT TECHNOLOGIES (up 72.5%), L&T TECHONOLOGY SERVICES (up 66.8%) and VINATI ORG. (up 62.5%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 (down 0.4%). The top gainers among the BSE Sensex stocks today are ONGC (up 1.0%). The most traded stocks in the BSE Sensex are ICICI BANK and RELIANCE IND..

In the meantime, NSE Nifty is at 10,928 (down 0.4%). ONGC (up 1.1%) and POWER GRID (up 0.8%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.3%).

HSIL LTD Financial Update...

HSIL LTD net profit down at Rs 47 million for the quarter ended September 2018, compared to a loss of Rs 156 million a year ago. Net Sales rose 7.6% to Rs 6.2 billion during the period as against Rs 5.8 billion in July-September 2017.

For the year ended March 2018, HSIL LTD reported 19.6% decrease in net profit to Rs 806.0 million compared to net profit of Rs 1.0 billion during FY17.

Revenue of the company grew 2.6% to Rs 23 billion during FY18.

The current Price to earnings ratio of HSIL LTD, based on rolling 12 month earnings, stands at 36.5x.

This article (HSIL LTD Plunges by 6%; BSE 500 Index Down 0.4%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/s2WMiFRThFU/indian-share-markets-updates.asp

Sensex Opens Flat; Sun Pharma Falls Over 9.2%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.6% while the Hang Seng is up 1%. The Nikkei 225 is trading up by 1.3%. US stocks advanced on Thursday as a published report that the United States was considering lifting tariffs on Chinese imports lifted investor sentiment.

Back home, India share markets opened on a flattish note with a positive bias. The BSE Sensex is trading up by 69 points while the NSE Nifty is trading up by 15 points. The BSE Mid Cap index and BSE Small Cap index opened up by 0.2% & 0.1% respectively.

Sectoral indices have opened the day on a mixed note with oil & gas stocks and bank stocks witnessing maximum buying interest. While, healthcare stocks and IT stocks have opened the day in red.

The rupee is currently trading at Rs 71.02 against the US$.

In the news from the economy. As per India Ratings and Research (Ind-Ra), Indian economy is likely to grow a tad higher at 7.5% in 2019-20 on account of steady improvement in major sectors.

According to the Central Statistics Office (CSO), the economy may clock a growth rate of 7.2% in the current financial year, up from 6.7% in the previous year.

After demonetisation and the GST implementation, the India Ratings had expected 2018-19 to be a year of quick recovery and, indeed, the recovery has been sharp with GDP growth coming in at 7.2%.

--- Advertisement ---
India is Set to Regain Its Lost Riches

REBIRTH OF INDIA India was the world's richest country nearly 2,000 years ago. In fact, we were referred to as the "Sone Ki Chidiya."

If you are like us who believe that India has the potential to be once again the "Sone Ki Chidiya" to the world again…and regain its status as one among the greatest countries on earth…

Then, I encourage you to join other true Indians in the first-ever mega summit "REBIRTH OF INDIA" for FREE.

This is our LARGEST EVER FREE PUBLIC SUMMIT available for EVERY INDIAN CITIZEN.

Don't Miss it!

Click Here to Claim Your FREE Pass for this MEGA Summit…
------------------------------

It further said GDP growth would have been even better but for the global headwinds caused by an abrupt rise in crude oil prices and strengthening of the US dollar, among other factors.

Over the past few years, private final consumption expenditure and government final consumption expenditure have been the primary growth drivers of Indian economic growth.

Ind-Ra said it believes that investments are slowly but steadily gaining traction, with gross fixed capital formation growing 12.2% in the current fiscal and projected to clock 10.3% in the next year.

But the flip side of this development is that it is primarily driven by the government capex (capital expenditure), as incremental private corporate capex has yet to revive.

It further said that due to the slowdown in private corporate and household capex, GDP growth has failed to accelerate and sustain itself close to or in excess of 8%.

Speaking of GDP growth, have a look at the latest data projecting the nominal GDP of countries by the year 2030.

India in the Pecking Order of Strongest Economies in Another Decade

As you can see in the chart, China would be by far the strongest economy in another decade. In fact, its GDP could be more than double of America's.

But that India will be a close second.

With GDP crossing 40 trillion dollars, the Indian economy will be at least a third bigger than the US.

No doubt the 40 trillion-dollar GDP will not come without some hiccups.

But once you know the stocks that could gain the most in the coming decade, you too be saying - 'Buy Indian. I am'.

Moving on to the news from pharma sector. As per an article in a leading financial daily, Aurobindo Pharma has agreed to acquire a portfolio of seven branded oncology injectable products from Spectrum Pharmaceuticals Inc.

Reportedly, the acquisition involves an upfront payment of US$160 million in cash, plus up to US$140 million on achieving regulatory and sales-based milestones. The acquisition also gives Aurobindo a branded commercial infrastructure in the US.

Acrotech Biopharma LLC, a wholly-owned subsidiary of Aurobindo Pharma USA Inc. will acquire the assets on a debt free and cash free basis.

The acquisition will help Aurobindo enter the branded oncology market with a range of products that are well recognized by the oncology community. Aurobindo Group will also acquire a well-established and experienced branded commercial infrastructure to continue commercializing these brands, the reports noted.

Spectrum, as part of its strategic shift to focus on novel oncology drug development and commercialization of its two late-stage pipeline products, carved out its commercial business inclusive of seven marketed oncology injectable products, intellectual property and commercial infrastructure for sale.

Aurobindo Pharma share price opened the day up by 0.5%.

To know more about the company, you can access to Aurobindo Pharma's Q2FY19 result analysis and Aurobindo Pharma FY18 annual report analysis on our website.

And to know what's moving the Indian stock markets today, check out the most recent share market updates here.



This article (Sensex Opens Flat; Sun Pharma Falls Over 9.2%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/wIs3tcL-cE0/tm.asp

GUJ. STATE PETRONET Surges by 5%; BSE OIL & GAS Index Up 0.1%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

GUJ. STATE PETRONET share price has zoomed 5% and is presently trading at Rs 187.

Meanwhile, the BSE OIL & GAS Index is at 13,619 (up 0.1%).

Among the top Gainers in the BSE OIL & GAS Index today is GUJ. STATE PETRONET (up 5.5%).

OIL INDIA LTD. (down 0.1%) and HPCL (down 0.6%) are among the top losers today.

Over the last one year, GUJ. STATE PETRONET has moved down from Rs 221 to Rs 187, registering a loss of Rs 34 (down 15.5%).

On the other hand, the BSE OIL & GAS has moved down from 15,967 to 13,619, loss of 2,348 points (down 15.2%) during the last 12 months.

The top gainers among the BSE OIL & GAS Index stocks during this same period were RELIANCE IND. (up 23.1%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 (down 0.2%).

The top gainers among the BSE Sensex stocks today are ONGC (up 0.9%), POWER GRID (up 0.6%) and RELIANCE IND. (up 0.4%). Other gainers include MARUTI SUZUKI (up 0.3%) and HERO MOTOCORP (up 0.3%). The most traded stocks in the BSE Sensex are RELIANCE IND. and TATA STEEL.

In the meantime, NSE Nifty is at 10,928 (down 0.2%). ONGC (up 1.1%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.5%).

GUJ. STATE PETRONET Financial Update...

GUJ. STATE PETRONET net profit stood at Rs 3 billion for the quarter ended September 2018, compared to a profit of Rs 2 billion a year ago. Net Sales rose 65.8% to Rs 6.0 billion during the period as against Rs 3.6 billion in July-September 2017.

For the year ended March 2018, GUJ. STATE PETRONET reported 34.6% increase in net profit to Rs 6.7 billion compared to net profit of Rs 5.0 billion during FY17.

Revenue of the company grew 29.6% to Rs 13 billion during FY18.

The current Price to earnings ratio of GUJ. STATE PETRONET, based on rolling 12 month earnings, stands at 13.1x.

This article (GUJ. STATE PETRONET Surges by 5%; BSE OIL & GAS Index Up 0.1%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/Gl7HY4LezZo/indian-share-markets-updates.asp

SUN PHARMA Plunges by 10%; BSE HEALTHCARE Index Down 1.8%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

SUN PHARMA share price has plunged 10% and is presently trading at Rs 426.

Meanwhile, the BSE HEALTHCARE Index is at 14,091 (down 1.8%).

Among the top losers in the BSE HEALTHCARE Index today is SUN PHARMA (down 10.1%).

CAPLIN POINT (up 1.7%) and ABBOTT INDIA (up 0.9%) are among the top gainers today.

Over the last one year, SUN PHARMA has moved down from Rs 583 to Rs 426, registering a loss of Rs 158 (down 27.1%)..

The BSE HEALTHCARE has moved down from 14,973 to 14,091, loss of 882 points (down 5.9%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 49.9%), SANOFI INDIA (up 36.2%) and TORRENT PHARMA (up 35.2%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 . The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.4%). The most traded stocks in the BSE Sensex are RELIANCE IND. and SBI.

In the meantime, NSE Nifty is at 10,928 (down 0.2%). POWER GRID (up 0.9%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.7%).

SUN PHARMA Financial Update...

SUN PHARMA net profit down at Rs 1 billion for the quarter ended September 2018, compared to a loss of Rs 4 billion a year ago. Net Sales rose 4.3% to Rs 69.4 billion during the period as against Rs 66.5 billion in July-September 2017.

For the year ended March 2018, SUN PHARMA reported 54.3% decrease in net profit to Rs 35.8 billion compared to net profit of Rs 78.4 billion during FY17.

Revenue of the company grew 16.1% to Rs 265 billion during FY18.

The current Price to earnings ratio of SUN PHARMA, based on rolling 12 month earnings, stands at 31.2x.

This article (SUN PHARMA Plunges by 10%; BSE HEALTHCARE Index Down 1.8%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/vzUUbwYmYvQ/indian-share-markets-updates.asp

SUN PHARMA ADV. RES. Plunges by 7%; BSE 500 Index Down 0.0%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

SUN PHARMA ADV. RES. share price has plunged 7% and is presently trading at Rs 173.

Meanwhile, the BSE 500 Index is at 14,557 .

Among the top losers in the BSE 500 Index today are SUN PHARMA ADV. RES. (down 6.5%) and CYIENT LTD (down 5.5%).

CROMPTON GREAVES CONSUMER ELEC. (up 3.5%) and TV TODAY NETWORK (up 2.1%) are among the top gainers today.

Over the last one year, SUN PHARMA ADV. RES. has moved down from Rs 509 to Rs 173, registering a loss of Rs 336 (down 65.9%)..

The BSE 500 has moved down from 15,328 to 14,557, loss of 771 points (down 5.0%) during the last 12 months.

The top gainers among the BSE 500 Index stocks during this same period were L&T TECHONOLOGY SERVICES (up 73.5%), NIIT TECHNOLOGIES (up 72.3%) and VINATI ORG. (up 62.7%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 . The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.3%). The most traded stocks in the BSE Sensex are RELIANCE IND. and SBI.

In the meantime, NSE Nifty is at 10,928 (down 0.1%). RELIANCE IND. (up 1.3%) and ONGC (up 0.9%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.7%).



This article (SUN PHARMA ADV. RES. Plunges by 7%; BSE 500 Index Down 0.0%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/YuV11Lsq_c0/indian-share-markets-updates.asp

RALLIS Plunges by 5%; BSE 500 Index Flat


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

RALLIS share price has plunged 5% and is presently trading at Rs 169.

Meanwhile, the BSE 500 Index is at 14,557 .

Among the top losers in the BSE 500 Index today are RALLIS (down 5.2%) and CYIENT LTD (down 5.5%).

CROMPTON GREAVES CONSUMER ELEC. (up 3.5%) and TV TODAY NETWORK (up 2.1%) are among the top gainers today.

Over the last one year, RALLIS has moved down from Rs 276 to Rs 169, registering a loss of Rs 107 (down 38.8%)..

The BSE 500 has moved down from 15,328 to 14,557, loss of 771 points (down 5.0%) during the last 12 months.

The top gainers among the BSE 500 Index stocks during this same period were L&T TECHONOLOGY SERVICES (up 73.5%), NIIT TECHNOLOGIES (up 72.3%) and VINATI ORG. (up 62.7%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 . The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.3%). The most traded stocks in the BSE Sensex are RELIANCE IND. and SBI.

In the meantime, NSE Nifty is at 10,928 (down 0.1%). RELIANCE IND. (up 1.3%) and ONGC (up 0.9%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.7%).

RALLIS Financial Update...

RALLIS net profit stood at Rs 851 million for the quarter ended September 2018, compared to a profit of Rs 249 million a year ago. Net Sales rose 67.6% to Rs 6.5 billion during the period as against Rs 3.9 billion in July-September 2017.

For the year ended March 2018, RALLIS reported 20.4% increase in net profit to Rs 1.7 billion compared to net profit of Rs 1.4 billion during FY17.

Revenue of the company grew 2.3% to Rs 18 billion during FY18.

The current Price to earnings ratio of RALLIS, based on rolling 12 month earnings, stands at 17.3x.

This article (RALLIS Plunges by 5%; BSE 500 Index Flat) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/fC9I5MJUhUU/indian-share-markets-updates.asp

SUN PHARMA Plunges by 10%; BSE HEALTHCARE Index Down 1.6%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

SUN PHARMA share price has plunged 10% and is presently trading at Rs 426.

Meanwhile, the BSE HEALTHCARE Index is at 14,091 (down 1.6%).

Among the top losers in the BSE HEALTHCARE Index today is SUN PHARMA (down 10.0%).

NATCO PHARMA (up 1.9%) and SYNGENE INTERNATIONAL (up 1.6%) are among the top gainers today.

Over the last one year, SUN PHARMA has moved down from Rs 583 to Rs 426, registering a loss of Rs 158 (down 27.1%)..

The BSE HEALTHCARE has moved down from 14,973 to 14,091, loss of 882 points (down 5.9%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 49.9%), SANOFI INDIA (up 36.2%) and DIVIS LABORATORIES (up 35.2%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 (up 0.2%). The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.7%). The most traded stocks in the BSE Sensex are YES BANK and RELIANCE IND..

In the meantime, NSE Nifty is at 10,928 (up 0.1%). RELIANCE IND. (up 1.6%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.9%).

SUN PHARMA Financial Update...

SUN PHARMA net profit down at Rs 1 billion for the quarter ended September 2018, compared to a loss of Rs 4 billion a year ago. Net Sales rose 4.3% to Rs 69.4 billion during the period as against Rs 66.5 billion in July-September 2017.

For the year ended March 2018, SUN PHARMA reported 54.3% decrease in net profit to Rs 35.8 billion compared to net profit of Rs 78.4 billion during FY17.

Revenue of the company grew 16.1% to Rs 265 billion during FY18.

The current Price to earnings ratio of SUN PHARMA, based on rolling 12 month earnings, stands at 31.2x.

This article (SUN PHARMA Plunges by 10%; BSE HEALTHCARE Index Down 1.6%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/EvWblBJ_vN8/indian-share-markets-updates.asp

CYIENT LTD Plunges by 6%; BSE IT Index Down 0.1%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

CYIENT LTD share price has plunged 6% and is presently trading at Rs 600.

Meanwhile, the BSE IT Index is at 14,671 (down 0.1%).

Among the top losers in the BSE IT Index today is CYIENT LTD (down 6.0%).

SONATA SOFTWARE (up 2.1%) and ECLERX SERVICES (up 0.8%) are among the top gainers today.

Over the last one year, CYIENT LTD has moved up from Rs 590 to Rs 600, registering a gain of Rs 10 (up 1.8%)..

The BSE IT has moved up from 12,183 to 14,671, registering a gain of 2,488 points (up 20.4%) during the last 12 months.

The top gainers among the BSE IT Index stocks during this same period were L&T TECHONOLOGY SERVICES (up 73.8%), NIIT TECHNOLOGIES (up 72.3%) and L&T INFOTECH LTD (up 60.7%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 (up 0.2%). The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.7%). The most traded stocks in the BSE Sensex are YES BANK and RELIANCE IND..

In the meantime, NSE Nifty is at 10,928 (up 0.1%). RELIANCE IND. (up 1.6%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.9%).

CYIENT LTD Financial Update...

CYIENT LTD net profit stood at Rs 1 billion for the quarter ended September 2018, compared to a profit of Rs 1 billion a year ago. Net Sales rose 20.7% to Rs 11.9 billion during the period as against Rs 9.8 billion in July-September 2017.

For the year ended March 2018, CYIENT LTD reported 19.9% increase in net profit to Rs 4.2 billion compared to net profit of Rs 3.5 billion during FY17.

Revenue of the company grew 8.6% to Rs 39 billion during FY18.

The current Price to earnings ratio of CYIENT LTD, based on rolling 12 month earnings, stands at 15.2x.

This article (CYIENT LTD Plunges by 6%; BSE IT Index Down 0.1%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/8L2lgnmEWcY/indian-share-markets-updates.asp

BAJAJ CORP Plunges by 5%; BSE FMCG Index Up 0.3%


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

BAJAJ CORP share price has plunged 5% and is presently trading at Rs 373.

Meanwhile, the BSE FMCG Index is at 11,985 (up 0.3%).

Among the top losers in the BSE FMCG Index today is BAJAJ CORP (down 5.0%).

EMAMI LTD (up 2.0%) and P&G HYGIENE (up 1.2%) are among the top gainers today.

Over the last one year, BAJAJ CORP has moved down from Rs 517 to Rs 373, registering a loss of Rs 144 (down 27.9%)..

The BSE FMCG has moved up from 10,738 to 11,985, registering a gain of 1,247 points (up 11.6%) during the last 12 months.

The top gainers among the BSE FMCG Index stocks during this same period were NESTLE (up 44.1%), BRITANNIA (up 34.7%) and HUL (up 28.0%).

What About the Benchmark Indices?

The BSE Sensex is at 36,470 (up 0.2%). The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 1.7%). The most traded stocks in the BSE Sensex are YES BANK and RELIANCE IND..

In the meantime, NSE Nifty is at 10,928 (up 0.1%). RELIANCE IND. (up 1.6%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,082 to 36,470, registering a gain of 1,388 points (up 3.9%).

BAJAJ CORP Financial Update...

BAJAJ CORP net profit stood at Rs 601 million for the quarter ended December 2018, compared to a profit of Rs 552 million a year ago. Net Sales rose 10.3% to Rs 2.3 billion during the period as against Rs 2.1 billion in October-December 2017.

For the year ended March 2018, BAJAJ CORP reported 10.8% decrease in net profit to Rs 2.1 billion compared to net profit of Rs 2.4 billion during FY17.

Revenue of the company grew 4.0% to Rs 8 billion during FY18.

The current Price to earnings ratio of BAJAJ CORP, based on rolling 12 month earnings, stands at 24.6x.

This article (BAJAJ CORP Plunges by 5%; BSE FMCG Index Up 0.3%) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.


Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/B-m1TCUGHgo/indian-share-markets-updates.asp

Global Stock Market Drivers; HUL, Reliance Industries Q3FY19 Results and Top Stocks in Action Today


Posted by Equitymaster
Facebook  Twitter  Visit Equitymaster on Google Plus!  More...

On Thursday, the Indian share markets were trading in a narrow range in afternoon trade amid weakness in public sector banks (PSU) and pharmaceuticals stocks.

At the closing bell, the Sensex ended up 53 points at 36375, while Nifty was up 15 points at 10,905.

HCL Tech and Axis Bank were the top gainers on the Sensex, while top losers were Sun Pharma and Yes Bank.

The rupee moved in a range of 71.09-71.37 against the US dollar. The domestic unit had settled at 71.24 against the greenback on Wednesday.

Top Stocks in Focus

L&T share price will be in focus today as Larsen & Toubro (L&T) Hydrocarbon Engineering has bagged two projects from the world's largest oil company Saudi Aramco.

Federal Bank reported a 28% rise in its year-on-year net profit for the December quarter at Rs 33.4 billion from Rs 2.6 billion last year.

Bharat Heavy Electricals Limited will set up a network of Solar-based Electric Vehicle Chargers (SEVC) on the Delhi-Chandigarh Highway. The project is covered under the Faster Adoption and Manufacturing of Electric Vehicles in India of the Department of Heavy Industry (DHI).

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Acetazolamide ER Capsules. It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad. Cadila Healthcare will be in focus.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

--- Advertisement ---
India is Set to Regain Its Lost Riches

REBIRTH OF INDIA India was the world's richest country nearly 2,000 years ago. In fact, we were referred to as the "Sone Ki Chidiya."

If you are like us who believe that India has the potential to be once again the "Sone Ki Chidiya" to the world again…and regain its status as one among the greatest countries on earth…

Then, I encourage you to join other true Indians in the first-ever mega summit "REBIRTH OF INDIA" for FREE.

This is our LARGEST EVER FREE PUBLIC SUMMIT available for EVERY INDIAN CITIZEN.

Don't Miss it!

Click Here to Claim Your FREE Pass for this MEGA Summit…
------------------------------

Results Corner

L&T Infotech, Dhanlaxmi Bank, Kajaria Ceramics, Wipro, MPS, Atul, HUL, Reliance Industries are among a few companies that will report its Q3FY19 results today.

Global Stock Market Drivers

On Thursday, US equity futures and European shares fell after a mixed session in Asia as concerns about rising tension between America and China offset signs of a better-than-expected start to the earnings season.

Further, emerging market currencies and shares declined. Shares in Hong Kong tumbled, with some companies dropping more than 75%.

The dollar was steady, and Treasuries edged higher.

Here are some key events coming up:

  • Earnings season rolls on with Morgan Stanley and Netflix posting results.
  • Data on US jobless claims and industrial production are due.
  • Eurozone inflation is scheduled today

Oil Prices Slide

Oil prices dipped on Thursday as US crude production quickly approached an unprecedented 12 million barrels per day (bpd) just as worries about weakening demand emerge.

US West Texas Intermediate (WTI) crude futures were at US$52 per barrel, down 0.6%, from their last settlement.

International Brent crude oil futures were down 0.6%, at US$60.98 per barrel.

American crude oil production reached a record 11.9 million bpd in the week ending January 11, the Energy Information Administration (EIA) said on Wednesday, up from 11.7 million bpd last week, which was already the highest national output in the world.

Note that, US output has soared by 2.4 million bpd since January 2018, stoking fears of a supply glut.

From the IPO Space...

As per an article in a leading financial daily, after a three-month drought in the Indian primary market, several companies, including cables and consumer electronic goods maker Polycab Wires Pvt. Ltd and hotel operator Chalet Hotels Ltd, are gearing up for their public offers.

Besides, Polycab and Chalet Hotels, Harsha Engineers Ltd, Dodla Dairy Ltd and Indiamart Intermesh Ltd are also looking to launch IPOs.

The Indian equity markets witnessed extreme ups and downs during the three months owing to the liquidity crisis in the NBFC space, macroeconomic headwinds, such as a depreciating rupee and high crude price, and concerns over state election results.

With so many IPOs set to hit the markets, we at Equitymaster believe a merit-based selection, primarily including valuation, business, and management quality, is the logical way to go about investing in IPOs.

If it means going against the herd, so be it. And going by recent past, this strategy has been proven to be successful more often.

To know how to safely profit from the ongoing IPO rush, download this FREE report now and discover How to Get Rich with IPOs.



This article (Global Stock Market Drivers; HUL, Reliance Industries Q3FY19 Results and Top Stocks in Action Today) is authored by Equitymaster.

Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

Click here to Read full Details Sources @ http://feeds.equitymaster.com/~r/TodaysMarket/~3/ZZDoL7_GA8s/tm.asp

SHARE THIS


Subscribe via Email


Explore Jobs/Opportunities
Jobs Jobs / Opportunities / Career
Haryana Jobs / Opportunities / Career
Bank Jobs / Opportunities / Career
Delhi Jobs / Opportunities / Career
Sarkari Naukri Jobs / Opportunities / Career
Uttar Pradesh Jobs / Opportunities / Career
Bihar Jobs / Opportunities / Career
Himachal Pradesh Jobs / Opportunities / Career
Rajasthan Jobs / Opportunities / Career
Scholorship Jobs / Opportunities / Career
Engineering Jobs / Opportunities / Career
Railway Jobs / Opportunities / Career
Defense & Police Jobs / Opportunities / Career
Gujarat Jobs / Opportunities / Career
West Bengal Jobs / Opportunities / Career
Uttarakhand Jobs / Opportunities / Career
Maharashtra Jobs / Opportunities / Career
Punjab Jobs / Opportunities / Career
Meghalaya Jobs / Opportunities / Career
Admission Jobs / Opportunities / Career
Explore Articles / Stories
Education
Government Schemes
News
Career
Admit Card
Bihar
State Government Schemes
Study Material
Technology
DATA
Public Utility Forms
Travel
Sample Question Paper
Exam Result
Employment News
Scholorship
Syllabus
Festival
Business
Wallpaper
Explore more
Main Page
Register / Login
Like our Facebook Page
Follow on Twitter
Subscrive Our Newsletter Via Nuzzle
Get Updates Via Rss Feed
Sarkari Niyukti
Free Online Practice Set
Latest Jobs
Feed contents
Useful Links
Photo
Video
Post Jobs
Post Contents
Supremedeal : India Business Directory
Find IFSC Code
Find Post Office / Pincode
Contact us
Best Deal

Disclaimer: we only provide job information. we are not associated with any job website. Although we take extreme care for accuracy of the information provided, but you must check the authenticity of the website before applying for the job. We are not responsible for your operation , once you leave our website and apply thereafter. Please recheck the genuineness of the job website from yourself also.

Copyright © 2018. Website template by WebThemez.com